Earnings Preview — 5182 total
HCW Biologics Inc. reports today with one of the most aggressively shorted lending setups in the small-cap biotech universe — a rare combination of sky-high short interest, near-maximum cost to borrow, and a lending…
DLocal heads into its May 15 results day with short sellers meaningfully more committed than they were a month ago — and options traders growing more cautious alongside them. Short interest climbed to 8.4% of the free…
The Glimpse Group, Inc. carries a consistent pattern of sharp post-earnings declines into today's print, and the positioning data does little to suggest this time feels different. The earnings history is the starkest…
AVX heads into tonight's earnings release with short sellers in full retreat — a sharp reversal from extreme positioning just weeks ago. The borrow market tells the clearest story. Short interest collapsed 67% over the…
NXGL heads into its May 15 earnings report as a micro-cap medical device company with a lending market that tells a surprisingly relaxed story — even as short interest has surged sharply in recent weeks. The most…
IDAI heads into its Q1 2026 results tonight carrying a visible contradiction: revenue grew 39% year-over-year, yet the company still missed both its EPS and sales estimates. The numbers filed after the close tell the…
Leslie's, Inc. heads into Monday's May 18 event carrying one of the most violent short-squeeze setups in the specialty retail space right now. The stock erupted 145% in a single session after the company's Q2 2026…
Nurix Therapeutics heads into today's earnings print as one of the more heavily shorted names in clinical-stage biotech, with short sellers retaining a firm grip on the stock. Short interest is running at roughly 21.9%…
A2Z Cust2Mate Solutions Corp. reports Q1 2026 results today with its short interest near a one-month high and options traders the most defensive they have been in weeks. The options market has turned sharply cautious…
CISO Global Inc. reports Q1 2026 results today against an unusual backdrop: a micro-cap cybersecurity firm with a market cap of roughly $13 million, a stock up 10% on the day and 13.5% on the week, yet down 12% over…
NeoVolta Inc. heads into its Q3 2026 earnings print with a lending market that remains meaningfully tight and a short position that, while easing this week, still holds over 10% of the free float. The clearest signal…
MTVA heads into its May 18 earnings print carrying one of the most expensive borrow costs in the biotech universe — a signal that short-side pressure, while not dominant by position size, is punishingly costly to…
KULR Technology Group reports today with one of the most constrained borrow markets in its peer universe — and a stock that just rallied 40% in a week, creating a tense setup for the print. Short sellers have built an…
Bit Digital reports Q1 2026 results today with options traders at their most bullish in a year — a sharp contrast to the elevated short position still sitting in the stock. The options signal is striking. The put/call…
PRPO dropped its Q1 2026 results after the close on May 14, delivering a revenue beat alongside a deeper-than-year-ago loss — the kind of split verdict that leaves investors doing the math on growth versus…
Voyager Therapeutics reports today with one striking contradiction: the stock is up 10% over the past month, yet executives have been consistently selling into that strength. The insider signal is the standout here.…
BT Brands heads into its May 15 earnings report having already delivered the headline: Q1 2026 results dropped after the close on May 14, showing EPS of -$0.12 against -$0.05 a year ago, and revenue of $2.84M against…
Arcadia Biosciences heads into its May 15 earnings report as one of the more technically distressed micro-caps on Nasdaq, with the stock down nearly 50% year-to-date and trading at $1.07. The price tells the clearest…
XBiotech Inc. heads into today's earnings print with options positioning at its most defensive level in months — a sharp divergence from an otherwise quiet short-selling picture. The clearest signal is in options. The…
enCore Energy heads into today's Q1 2026 earnings event already having delivered the print — and the numbers are better than the Street expected. Q1 EPS came in at $0.03 against a consensus estimate of -$0.08. Revenue…
